20.25
+0.61(+3.11%)
Currency In USD
| Previous Close | 19.64 |
| Open | 19.6 |
| Day High | 20.35 |
| Day Low | 19.6 |
| 52-Week High | 20.65 |
| 52-Week Low | 7 |
| Volume | 93,725 |
| Average Volume | 76,160 |
| Market Cap | 418.83M |
| PE | -4.05 |
| EPS | -5 |
| Moving Average 50 Days | 16.36 |
| Moving Average 200 Days | 12.96 |
| Change | 0.61 |
If you invested $1000 in Amarin Corporation plc (AMRN) 10 years ago, it would be worth $524.61 as of October 21, 2025 at a share price of $20.25. Whereas If you bought $1000 worth of Amarin Corporation plc (AMRN) shares 5 years ago, it would be worth $214.51 as of October 21, 2025 at a share price of $20.25.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025
GlobeNewswire Inc.
Oct 15, 2025 12:00 PM GMT
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report third quarter 2025 financial re
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
GlobeNewswire Inc.
Oct 14, 2025 12:00 PM GMT
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, in collaboration with its Canadian partner HLS Therapeutics, a phar
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
GlobeNewswire Inc.
Aug 31, 2025 12:30 PM GMT
-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action --DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 31, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted in vitro data assessing the